QuantiScientifics
Private Company
Funding information not available
Overview
QuantiScientifics is a privately-held, US-based biotech firm founded in 2015 that operates at the intersection of diagnostics and AI/machine learning. The company has developed a proprietary multiplex assay platform (A2 technology) that simplifies and accelerates the creation of custom immunoassays for research and diagnostic use. It generates revenue through the sale of assay plates, kits, and contract research/consulting services, primarily targeting the food allergy and sensitivity testing markets. Leadership is anchored by its founder, an experienced inventor in microarray technology, indicating a deep technical foundation.
Technology Platform
A-squared (A2) oligo-link technology for creating multiplex antibody microarrays in standard well plates via oligonucleotide hybridization, without printing.
Opportunities
Risk Factors
Competitive Landscape
QuantiScientifics competes in the multiplex immunoassay space against large diversified players like Luminex (xMAP), Meso Scale Discovery (MSD), and Thermo Fisher, as well as other niche assay developers. Its differentiation lies in the simplicity and customizability of its plate-based, printing-free A2 platform for research and specialty diagnostic applications.